四、FDA510K评审周期
Day 1:FDA receives 510(K) submission
By Day 7
FDA sends Acknowledgement Letter.OR
FDA sends Hold Letter if unresolved issues with User Fee and/or eCpoy.
By Day 15:
FDA conducts Acceptance Review.
FDA informs submitter if 510(K) is accepted for Substantive Review or placed on RTA Hold.
By Day 60:
FDA conducts Substantive Review.
FDA communicates via a Substantive Interaction to inform the sunmitter that the FDA will either proceed with Ineractive Review or that 510(K) will be placed on hold and Additional Information is required.
By Day 90:
FDA sends final MDUFA Decision on 510(K).
By Day 100:
If MDUFA Decision is not reached by Day 100,FDA Provides Missed MDUFA Decision Communication that identifines outstanding review issues.
具体可来电详谈。